Trials / Completed
CompletedNCT00445172
A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and efficacy of long-term E0302 administration in patients with Amyotrophic Lateral Sclerosis (ALS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E0302 (mecobalamin) | Intramuscular injection, mecobalamin twice a week. |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2017-03-31
- Completion
- 2017-03-31
- First posted
- 2007-03-08
- Last updated
- 2023-06-18
Locations
42 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00445172. Inclusion in this directory is not an endorsement.